Dr. Sanjaya Kumar Satapathy, MD

Dr. Satapathy practices at Northwell Health Physician Partners Cardiology in Manhasset, New York.

Dr. Satapathy's NPI, 1700185089, was assigned on March 25, 2011. Dr. Satapathy holds Tennessee license MD0000047432.

Dr. Satapathy's primary practice is Northwell Health Physician Partners Cardiology, at 400 Community Dr, Manhasset, NY 11030 in Nassau County. The practice phone is (516) 321-7400.

Dr. Satapathy's primary practice is Northwell Health Physician Partners Cardiology in Manhasset, New York. Dr. Satapathy is also affiliated with North Shore University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Satapathy to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Satapathy practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Satapathy's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Satapathy is licensed in Tennessee.

CMS data shows 562 Medicare services from Dr. Satapathy across 7 procedure codes in 2024, for 241 Medicare patients. Medicare paid $57,184 for them.

CMS counts 241 Medicare patients who saw Dr. Satapathy in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Satapathy's median patient age at 65, with 43% women.

In 2024, Dr. Satapathy wrote 611 Medicare Part D claims for 126 patients. 75% of them were for generic drugs. CMS names the drug for 405 of them, across 15 drugs with 11 or more claims each, at $296,210 in total drug cost. In 2023, CMS named 617 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Satapathy for performance year 2024, reported through an alternative payment model (APM). Dr. Satapathy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Satapathy as offering telehealth. CMS counts 36 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Satapathy, more than 58% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Satapathy to 1 clinical trial. Conditions studied include Liver Cirrhosis and Hepatitis C. Open Payments lists research payments to Dr. Satapathy that name 1 trial.

CMS Open Payments shows 186 general payments to Dr. Satapathy from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 36% of the total. Intercept Pharmaceuticals, Inc. paid the most, $24,417. It also lists 10 research payments totaling $2,543 from 2016 to 2025, naming 1 clinical trial.